2010 | Discovery of a highly selective turn-on fluorescent probe for Ag + | 윤주영 | Article |
2022 | Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease | 배윤수; 이화정 | Article |
2010 | Discovery of a new human A2A adenosine receptor agonist, truncated 2-hexynyl-4′-thioadenosine | 정낙신; 최선 | Article |
2007 | Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4′-thioadenosine derivatives without 4′-hydroxymethyl group as highly potent and selective antagonists | 정낙신; 이상국 | Article |
2009 | Discovery of a new template for anticancer agents: 2′-deoxy-2′- fluoro-4′-selenoarabinofuranosyl-cytosine (2′-F-4′-seleno-ara- C) | 정낙신; 이상국; 최선; 최원준 | Article |
2023 | Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy | 차선신 | Article |
2012 | Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing | 이상혁; 김재상; 정연주 | Article |
2018 | Discovery of an inhibitor of ESX-MED23 interaction as a novel strategy to overcome trastuzumab resistance in HER2 overexpressing human gastric cancer | 이화종 | Master's Thesis |
2022 | Discovery of an Intestine-specific FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis | 심소연 | Doctoral Thesis |
2021 | Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity Shift | 최선; 이윤지 | Article |
2008 | Discovery of Cancer Biomarkers using Public EST and Microarray Data | 신영아 | Doctoral Thesis |
2019 | Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design | 최선 | Article |
2014 | Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor | 권영주 | Article |
2023 | Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer | 유진하 | Article |
2022 | Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial | 김완규 | Article |
2019 | Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia | 김형래 | Article |
2018 | Discovery of Ezrin Expression as a Potential Biomarker for Chemically Induced Ocular Irritation Using Human Corneal Epithelium Cell Line and a Reconstructed Human Cornea-like Epithelium Model | 임경민 | Article |
2007 | Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system | 강상원 | Article |
2017 | Discovery of GPR40 Agonists as Potent Antidiabetic Agents | 안경미 | Doctoral Thesis |
2014 | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent | 신윤용; 이화정; 김대기 | Article |